Is Intramuscular Administration of Recombinant Human C1-Inhibitor an Alternative for the Treatment of Acute Attacks in Patients with Hereditary Angioedema?

被引：0
|
作者：
Staevska, Maria [1 ]
Valerieva, Anna [1 ]
机构：
[1] Med Univ Sofia, Clin Allergy & Asthma, Sofia, Bulgaria
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2018年 / 141卷 / 02期
关键词：
D O I：
10.1016/j.jaci.2017.12.187
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
185
引用
收藏
页码：AB58 / AB58
页数：1
相关论文
共 50 条
  • [21] Evaluation of the efficacy and safety of home treatment with the recombinant human C1-inhibitor in hereditary angioedema resulting from C1-inhibitor deficiency
    Andrasi, Noemi
    Veszeli, Nora
    Holdonner, Agnes
    Temesszentandrasi, Gyorgy
    Kohalmi, Kinga Viktoria
    Varga, Lilian
    Farkas, Henriette
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2020, 80
  • [22] Human pasteurized C1-inhibitor concentrate for the treatment of hereditary angioedema due to C1-inhibitor deficiency
    Bork, Konrad
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2011, 7 (06) : 723 - 733
  • [23] C1-INHIBITOR CONCENTRATE FOR TREATMENT OF HEREDITARY ANGIOEDEMA
    PHILLIPS, M
    NEW ENGLAND JOURNAL OF MEDICINE, 1980, 303 (09): : 526 - 527
  • [24] Treatment of attacks with plasma-derived C1-inhibitor concentrate in pediatric hereditary angioedema patients
    Farkas, Henriette
    Csuka, Dorottya
    Zotter, Zsuzsanna
    Szabo, Erika
    Czaller, Ibolya
    Varga, Lilian
    Fejes, Janos
    Fuest, George
    Harmat, George
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2013, 131 (03) : 909 - +
  • [25] Recombinant human C1 esterase inhibitor treatment for hereditary angioedema attacks in children
    Reshef, Avner
    Grivcheva-Panovska, Vesna
    Kessel, Aharon
    Kivity, Shmuel
    Klimaszewska-Rembiasz, Maria
    Moldovan, Dumitru
    Farkas, Henriette
    Gutova, Vaclava
    Fritz, Stephen
    Relan, Anurag
    Giannetti, Bruno
    Magerl, Markus
    PEDIATRIC ALLERGY AND IMMUNOLOGY, 2019, 30 (05) : 562 - 568
  • [26] Efficacy of Recombinant Human C1 Inhibitor Treatment for Abdominal Attacks of Hereditary Angioedema
    Suez, D.
    Moldovan, D.
    Baker, J. W.
    Kivity, S.
    Relan, A.
    Reshef, A.
    Levy, R.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2012, 129 (02) : AB222 - AB222
  • [27] EFFICACY OF RECOMBINANT HUMAN C1 INHIBITOR FOR THE TREATMENT OF HEREDITARY ANGIOEDEMA PATIENTS WITH SEVERE ATTACKS.
    Li, H.
    Reshef, A.
    Farkas, H.
    Baker, J.
    Porebski, G.
    McNeil, D.
    Relan, A.
    Zanichelli, A.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2014, 113 (05) : A5 - A5
  • [28] Efficacy and safety of recombinant human C1-inhibitor for the treatment of attacks of hereditary angioedema: European open-label extension study
    Moldovan, D.
    Reshef, A.
    Fabiani, J.
    Kivity, S.
    Toubi, E.
    Shlesinger, M.
    Triggiani, M.
    Montinaro, V.
    Cillari, E.
    Realdi, G.
    Cancian, M.
    Visscher, S.
    Zanichelli, A.
    Relan, A.
    Cicardi, M.
    CLINICAL AND EXPERIMENTAL ALLERGY, 2012, 42 (06): : 929 - 935
  • [29] Immunosafety of Recombinant Human C1-Inhibitor in Hereditary Angioedema: Evaluation of IgE Antibodies
    C. Erik Hack
    Anurag Relan
    Aartie Baboeram
    Beatrijs Oortwijn
    Serge Versteeg
    Ronald van Ree
    Rienk Pijpstra
    Clinical Drug Investigation, 2013, 33 : 275 - 281
  • [30] Population pharmacokinetics of subcutaneous C1-inhibitor for prevention of attacks in patients with hereditary angioedema
    Pawaskar, Dipti
    Tortorici, Michael A.
    Zuraw, Bruce
    Craig, Timothy
    Cicardi, Marco
    Longhurst, Hilary
    Li, H. Henry
    Lumry, William R.
    Martinez-Saguer, Inmaculada
    Jacobs, Joshua
    Bernstein, Jonathan A.
    Riedl, Marc A.
    Katelaris, Constance H.
    Keith, Paul K.
    Feussner, Annette
    Sidhu, Jagdev
    CLINICAL AND EXPERIMENTAL ALLERGY, 2018, 48 (10): : 1325 - 1332
12345